Lead party: Boehringer Ingelheim (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: DMRX Company Limited (private company) · Sector: Healthcare, Primary Care Providers · Countries of operation: Tanzania
Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: Social Engagement Fund (Boehringer Ingelheim)
Lead investor/buyer: Boehringer Ingelheim · Investors/buyers: Boehringer Ingelheim
Legal advisers: not identified in the source record.
Source: announced 16 July 2025. Original announcement: boehringer-ingelheim.com.


